/Companies

Sinaptica Therapeutics

Founded 2021 · 19 employees on LinkedIn · 7 known investors

Find your way into Sinaptica Therapeutics

Sign up to see every warm intro you have to Sinaptica Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Sinaptica Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sinaptica is a medical device company developing noninvasive brain modulation therapies for Alzheimer's disease, led by scientific experts and experienced medtech executives.

Founders & leadership

Sinaptica Therapeutics was founded in 2021 by Scientific Co-Founder (University of Ferrara) and Scientific Co-Founder (Harvard Medical School).

SCScientific Co-Founder (University of Ferrara)
Scientific Co-Founder (University of Ferrara)Scientific Co-Founder
SCScientific Co-Founder (Harvard Medical School)
Scientific Co-Founder (Harvard Medical School)Scientific Co-Founder

Investors · 7

In the news

Frequently asked questions

What does Sinaptica Therapeutics do?
Sinaptica is a medical device company developing noninvasive brain modulation therapies for Alzheimer's disease, led by scientific experts and experienced medtech executives.
Who founded Sinaptica Therapeutics?
Sinaptica Therapeutics was founded by Scientific Co-Founder (University of Ferrara), Scientific Co-Founder (Harvard Medical School) in 2021.
Who are Sinaptica Therapeutics's investors?
Sinaptica Therapeutics's investors include Bootstrap Venture Partners, Device of Tomorrow Capital, Healthtech Capital, NW Angel, Sony Ventures Corporation, Star51 Capital, Time Zero Capital.